Orchestra BioMed (OBIO) director awarded RSUs, options and tax shares withheld
Rhea-AI Filing Summary
Orchestra BioMed Holdings director compensation and tax withholding activity was reported through the Fain Living Trust. On June 23, 2026, the trust received 17,327 shares of Common Stock as a grant of restricted stock units, each representing one future share subject to service-based vesting after one year.
On the same date, the trust was granted 21,277 stock options with an exercise price of $4.04 per share, expiring on June 23, 2036, which also vest after one year of continuous service. On June 24, 2026, 4,261 shares were withheld by the issuer to cover tax obligations upon RSU vesting, with no market sale of shares. Following these transactions, the trust held 104,775 shares of Common Stock indirectly for the reporting person.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 13,066 shares
Net Buy
3 txns
Insider
Fain Eric S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 4,261 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 21,277 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.0001 per share ("Common Stock") | 17,327 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,277 shares (Indirect, By the Fain Living Trust);
Common Stock, par value $0.0001 per share ("Common Stock") — 109,036 shares (Indirect, By the Fain Living Trust);
Common Stock — 104,775 shares (Indirect, By the Fain Living Trust)
Footnotes (3)
- F1. Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 23, 2026 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.
- F2. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of RSUs. No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
- F3. The stock options will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.
Key Figures
RSU shares granted: 17,327 shares
Options granted: 21,277 options
Option exercise price: $4.04 per share
+3 more
6 metrics
RSU shares granted
17,327 shares
Restricted stock units granted on June 23, 2026
Options granted
21,277 options
Stock Option (Right to Buy) granted on June 23, 2026
Option exercise price
$4.04 per share
Conversion/exercise price for stock options
Option expiration
June 23, 2036
Expiration date of stock options
Shares withheld for taxes
4,261 shares
Withholding to satisfy RSU tax obligations on June 24, 2026
Shares held after transactions
104,775 shares
Indirect Common Stock holdings via Fain Living Trust after June 24, 2026
Key Terms
restricted stock units ("RSUs"), tax withholding obligations, Stock Option (Right to Buy), continuous service, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 23, 2026"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
tax withholding obligations financial
"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of RSUs"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 4.0400 and expiration date June 23, 2036"
continuous service financial
"The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date"
indirect ownership financial
"direct_or_indirect: "I", nature_of_ownership: "By the Fain Living Trust" indicating indirect ownership"
FAQ
What did Orchestra BioMed (OBIO) director Eric Fain report in this Form 4?
Eric Fain, through the Fain Living Trust, reported receiving restricted stock units and stock options, plus share withholding for taxes. The transactions reflect equity compensation and related tax settlements, with no open-market share purchases or sales disclosed in this filing.
What stock options did the Fain Living Trust receive in Orchestra BioMed (OBIO)?
The Fain Living Trust received stock options covering 21,277 shares of Orchestra BioMed Common Stock. These options have a strike price of $4.04 per share, vest after one year of continuous service from June 23, 2026, and expire on June 23, 2036.
When do the Orchestra BioMed (OBIO) RSUs and options granted to the Fain Living Trust vest?
Both the restricted stock units and the stock options granted on June 23, 2026 vest on the one-year anniversary of that grant date. Vesting is conditioned on the reporting person’s continuous service through that anniversary, as described in the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
